Compare SMSI & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SMSI | OSRH |
|---|---|---|
| Founded | 1982 | N/A |
| Country | United States | United States |
| Employees | N/A | 22 |
| Industry | Computer Software: Prepackaged Software | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 18.2M | 17.9M |
| IPO Year | 2017 | N/A |
| Metric | SMSI | OSRH |
|---|---|---|
| Price | $0.89 | $0.43 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 109.6K | ★ 1.6M |
| Earning Date | 04-29-2026 | 05-19-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 62.94 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $17,363,000.00 | N/A |
| Revenue This Year | $13.97 | $9.30 |
| Revenue Next Year | $53.35 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.41 | $0.38 |
| 52 Week High | $1.30 | $1.79 |
| Indicator | SMSI | OSRH |
|---|---|---|
| Relative Strength Index (RSI) | 62.49 | 38.66 |
| Support Level | $0.68 | $0.40 |
| Resistance Level | $0.93 | $0.47 |
| Average True Range (ATR) | 0.04 | 0.05 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 82.16 | 4.38 |
Smith Micro Software Inc provides software solutions that simplify and enhance the mobile experience to some of the wireless service providers around the globe. The company's solutions include SafePath product suite provides comprehensive and easy-to-use tools to protect family digital lifestyles and manage connected devices both inside and outside the home; CommSuite premium messaging platform helps mobile service providers deliver a next-generation voicemail experience to mobile subscribers, while monetizing a legacy cost-center; and ViewSpot its retail display management platform provided wireless carriers and retailers with a way to bring powerful on-screen, interactive demos to life. It operates in single segment: Wireless.
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. The company's pipeline products include: Vaximm, Darnatein, Woori IO, and RMC.